Alice Asher
Overview
Explore the profile of Alice Asher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Madera-Garcia V, Broz D, Baugher A, Hershow R, Dasgupta S, Asher A, et al.
Drug Alcohol Depend
. 2025 Mar;
270:112634.
PMID: 40043351
Background: Medications for opioid use disorder (MOUD) are key to preventing opioid overdose. Despite the high risk of opioid overdose among recently incarcerated people who use drugs, missed opportunities for...
2.
Bradley H, Luisi N, Carter A, Pigott T, Abramovitz D, Allen S, et al.
AIDS
. 2024 Nov;
39(4):434-447.
PMID: 39612241
Objective: Using an innovative data sharing model, we assessed the impacts of the COVID-19 pandemic on the health of people who inject drugs (PWID). Design: The PWID Data Collaborative was...
3.
Healy E, Means A, Knudtson K, Frank N, Juarez A, Prohaska S, et al.
Harm Reduct J
. 2024 Aug;
21(1):157.
PMID: 39192340
Background: Syringe services programs (SSPs) provide harm reduction supplies and services to people who use drugs and are often required by funders or partners to collect data from program participants....
4.
Board A, DAngelo D, Miele K, Asher A, von Essen B, Denny C, et al.
J Addict Med
. 2024 Jun;
18(6):711-714.
PMID: 38912696
Objectives: We aimed to determine the prevalence of self-reported naloxone use during pregnancy among people in the United States with a recent live birth. A secondary objective was to characterize...
5.
Chapin-Bardales J, Asher A, Broz D, Teshale E, Mixson-Hayden T, Poe A, et al.
Int J Drug Policy
. 2024 Mar;
:104387.
PMID: 38531730
Background: Characterizing acute and chronic hepatitis C virus (HCV) infection and HIV/HCV co-infection among persons who inject drugs (PWID) can inform elimination efforts. Methods: During 2018 National HIV Behavioral Surveillance...
6.
Bradley H, Austin C, Allen S, Asher A, Bartholomew T, Board A, et al.
Int J Drug Policy
. 2022 Nov;
110:103889.
PMID: 36343431
Background: People who inject drugs (PWID) have likely borne disproportionate health consequences of the COVID-19 pandemic. PWID experienced both interruptions and changes to drug supply and delivery modes of harm...
7.
Jeffers A, Meehan A, Barker J, Asher A, Montgomery M, Bautista G, et al.
Int J Environ Res Public Health
. 2022 Oct;
19(19).
PMID: 36231422
The United States is experiencing a syndemic of homelessness, substance use disorder, and mental health conditions, which has been further exacerbated by the COVID-19 pandemic. Although it is expected that...
8.
Bradley H, Hall E, Asher A, Furukawa N, Jones C, Shealey J, et al.
Clin Infect Dis
. 2022 Jul;
76(1):96-102.
PMID: 35791261
Background: Public health data signal increases in the number of people who inject drugs (PWID) in the United States during the past decade. An updated PWID population size estimate is...
9.
Hofmeister M, Asher A, Jones C, Augustine R, Burkholder C, Collins J, et al.
J Appalach Health
. 2022 Jun;
4(1):51-60.
PMID: 35769511
Background: People who use drugs are at increased risk for hepatitis A virus infection. Since 1996, the Advisory Committee on Immunization Practices has recommended hepatitis A vaccination for people who...
10.
Montgomery M, Zhong Y, Roberts E, Asher A, Bixler D, Doshani M, et al.
Drug Alcohol Depend
. 2022 Jun;
237:109540.
PMID: 35753280
Background: Syringe services programs (SSPs) are an important venue for reaching people who inject drugs (PWID) to offer preventive services; however, not all SSPs offer vaccinations. We aimed to describe...